Good bacteria: The microbiome, its vast therapeutic potential, and the challenges aheadPublished: April 2021 In the late 1950s a radical idea was born: What if a patients gastrointestinal inflammation could be cured by implanting a healthier gut? The result, now known as a fecal microbiota transplant, is the foundation of the microbiome industry. While the field is still in its commercial infancy, it is showing promise companies like Seres Therapeutics, Rebiotix, and Finch Therapeutics are already presenting mid and late stage clinical